Cellmid is best known in the personal care and health industry as the maker of the game-changing Evolis Professional brand. Launched in the Australian market in 2015, the range was the biggest breakthrough in topical hair loss treatments in 30 years.
The original technology was 12 years in development and Evolis quickly captured 70 per cent of the women’s hair loss market and 20 per cent of the men’s business.
Cellmid acquired BLC Cosmetics from HLG, the Australian investment holding and business service company, in November for $3 million. A leading importer of prestige skincare and well-being brands, including Thalgo, USPA, Kerstin Florian and HydroPeptide, BLC services more than 800 spas, clinics, salons, retail stores and DTC across Australia, New Zealand and the Pacific.
To underline its transition to a health and beauty tech business, Cellmid has changed its name to Anagenics Limited. Inspired by the Greek word for regeneration – anagennisi – the name change also references anagen, the growth phase of the hair cycle targeted by the company’s proprietary FGF5 inhibitor technology.
Anagenics has already expanded into China, Japan, Germany and the US and the company is poised for the next stage of its development and expansion, backed by its anti-ageing prowess, differentiated brands, global distribution footprint and growing revenues.